DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Amicus Therapeutics, Inc. (NASDAQ: FOLD)

13.75 -0.27 (-1.93%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FOLD $13.75 -1.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.04
Previous Close $14.02
Daily Range $13.42 - $14.05
52-Week Range $3.50 - $14.65
Market Cap $1.3B
P/E Ratio -14.79
Dividend (Yield) $0.00 (0.0%)
Volume 1,940,920
Average Daily Volume 2,623,776
Current FY EPS -$1.05




Drug Makers

Amicus Therapeutics, Inc. (FOLD) Description

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. Website:

News & Commentary

Why Shares in Amicus Therapeutics Shot Higher in June

Amicus Therapeutics shares jumped on news that it had filed for European approval of Galafold, a therapy for Fabry disease.

Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 Views

Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 Views

Morning Market Gainers

Keep An Eye On These 10 After-Hours Movers

Best Places to Invest in Biotechnology

One Foolish contributor shares his top large- and small-cap biotech stocks for portfolios.

MKM Looked To The Options Market To Find Its Top 10 M&A Targets

Is There Further Upside In Amicus Therapeutics?

Pier 1, BioMarin, HomeAway & Oracle Lead Wednesday's After-Hours Movers

Amicus Therapeutics (FOLD) in Focus: Stock Gains 7.9% - Tale of the Tape

See More FOLD News...

FOLD's Top Competitors

FOLD $13.75 (-1.93%)
Current stock: FOLD
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB